Project: A new medical device gel that reduces chronic inflammation and restores oral soft tissue health

Acronym OralG (Reference Number: 12432)
Duration 01/09/2018
Project Topic The aim of the project is to develop a medical device (MD) based on a new patented synthetic bifunctional peptide acting as a non-antibiotic, anti inflammatory wound healing agent for protections against severe periodontitis and peri-implantitis. Unmet medical needs regarding oral soft tissue management are specifically targeted thanks to a new gel against inflammation, avoiding loss of jaw-bone and painful regenerative procedures for patients and costs for both patients and public stakeholders.
Network Eurostars 2
Call Eurostars Cut–off 9

Project partner

Number Name Role Country
1 REGENTIS-PHARMA Coordinator France
2 CORTICALIS AS Partner Norway